Obtained from the ASAMS WEBSITE

This document was reproduced by ASAMS on its website with permission of its original Author. The Author has made this document available for public access on the strict understanding that the Author holds all Copyrights over this document and only under certain conditions. This document may be stored electronically and/or printed out for personal research and reference purposes ONLY. Any retransmission and/or reproduction for any other reason, whether in part or in whole, by any means, is prohibited unless permission is obtained by the Author.

 

Reference Works by Dr. Dewey Nelson
Dewey Nelson, M.D.

 

Nelson DA, Vates TS, Thomas JR. Complications from intrathecal steroid therapy in patients with multiple sclerosis. Neurology 1972;22:454.

Nelson DA, Vates TS, Thomas RB. Complications from intrathecal steroid therapy in patients with multiple sclerosis. Acta Neurologica Scandinavica 1973;49:176-188.

Nelson DA, Vates TS, Thomas RB. Complications from intrathecal steroid therapy in patients with multiple sclerosis. Yearbook Neurology, Neurosurgery and Psychiatry 1975;194-195.

Arachnoiditis from intrathecally given corticosteroids in the treatment. of multiple sclerosis. Arch Neurol 1976;33: 373.

Nelson DA, Abel R. Bernat JL. Complications from methylprednisolone acetate (DepoMedrol) when injected into the orbit, subarachnoid or subdural spaces. Del Med J 1977;49331-343.

Methylprednisolone acetate. Arch Neurol 1979;36: 661-662.

Dangers from methylprednisolone acetate therapy by intraspinal injection, (Neurologic Review). Arch Neurol 1988;45: 804-806.

Safety of intrathecal steroids in multiple sclerosis (A reply). Arch Neurol 1989;46:718-719.

Perceived dangers from intraspinal steroid injections (A reply) Arch Neurol 1989;46: 719-721.

Dangers from Methylprednisolone acetate therapy by intraspinal injection (A reply). Arch Neurol 1989;46;721-722.

Pain in multiple sclerosis, Neurology 1989;39;1000-1001.

Dangers from intraspinal steroid injections. Arch Neurol 1990;47:255.

Further warnings from Australia concerning intraspinal steroids. Arch Neurol 1990;48:25 9.

Intraspinal therapy using methylprednisolone acetate, twenty-three years of clinical controversy. Spine 1993;18: 278-286.